Aviso: Este sitio agrega datos públicos oficiales de la FDA, ClinicalTrials.gov, PubMed y SEC EDGAR solo como referencia general. No constituye asesoramiento médico, diagnóstico, recomendaciones de tratamiento ni asesoramiento de inversión.

PMA de la FDA

Transdermal test for Assessment of Glomerular Filtration Rate

Número de PMA: P230019 · 2026-06-10

SolicitanteMedibeacon, Inc.
Fecha de decisión2026-06-10
Número PMAP230019
Código de productoSDK
Clase del dispositivoClase 3
Especialidad médicaU
Comité asesorGU

Resumen del dispositivo

Transdermal test for Assessment of Glomerular Filtration Rate is the device name listed in this FDA 510(k) record. The listed applicant is Medibeacon, Inc.. It received FDA 510(k) clearance on 2026-06-10. The device is classified under product code SDK. It was reviewed by the GU advisory panel.

Preguntas frecuentes

What is the Transdermal test for Assessment of Glomerular Filtration Rate?

Transdermal test for Assessment of Glomerular Filtration Rate is a medical device that received FDA 510(k) clearance on 2026-06-10. The listed applicant is Medibeacon, Inc..

When did Transdermal test for Assessment of Glomerular Filtration Rate receive FDA 510(k) clearance?

The clearance date for Transdermal test for Assessment of Glomerular Filtration Rate can be found in the official FDA records.

Who is the listed applicant for Transdermal test for Assessment of Glomerular Filtration Rate?

The FDA 510(k) record lists Medibeacon, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Transdermal test for Assessment of Glomerular Filtration Rate?

The FDA product code for Transdermal test for Assessment of Glomerular Filtration Rate is SDK.

Ensayos clínicos relacionados

Los registros relacionados se emparejan automáticamente mediante nombres, códigos de producto u otros metadatos. Un emparejamiento no establece una relación clínica, científica, corporativa o regulatoria verificada; revise las fuentes oficiales enlazadas.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Fuente oficial

Ver en la base de datos de la FDA →

Datos procedentes de la API abierta de la FDA. Para obtener la información más actualizada y autoritativa, consulte siempre el registro oficial.

↑